Innocoll AG Appoints Charles Katzer as Head of Manufacturing and Technical Operations
“2016 is anticipated to be an important transitional year for Innocoll,” said
Throughout Mr. Katzer’s over 40-year career, he has been responsible for the leadership and direction of manufacturing, quality operations, product & process development, supply chain operations, and engineering functional disciplines in the biopharmaceutical industry. Most recently, he was the senior vice president of technical operations of
“Innocoll’s collagen matrix technologies, as evidenced by its advanced product pipeline, are platforms that provide significant potential to make medicines work better, and, therefore, offer ideal opportunities for long-term successful pharmaceutical product development and commercial success,” said Mr. Katzer. “I’m am looking forward to contributing to this success and to participate in the growth of the company in 2016 and beyond.”
Our proprietary, biocompatible, and biodegradable collagen products are precision-engineered for targeted use. Applied locally to wound and/or surgery sites, they are designed to provide a range of benefits.
Our robust, late-stage product pipeline is focused on addressing a number of significant unmet medical needs: INL-001, a bupivacaine-collagen bioresorbable implant (Phase III), is being studied to provide better postoperative analgesia; INL-002, a gentamicin-collagen topical matrix (Phase III), is being investigated as a topical treatment to better cure diabetic foot infections; and INL-003, a bioresorbable collagen film surgical adhesion barrier (approved ex-US), is scheduled to enter clinical trials in the US for the prevention of postsurgical adhesions.
Our currently approved products include: COLLAGUARD® (ex-US), COLLATAMP® G, SEPTOCOLL® E, REGENEPRO®, COLLACARE®, COLLEXA®, and ZORPREVA®, some of which are sold globally through strategic partnerships, including those with Takeda, EUSA Pharma, and Biomet. All of our native collagen products—from extraction/purification of type-1 collagen through final delivery form—are manufactured at our certified, integrated plant in Saal,
For more information, please visit www.innocoll.com.
CollaRx®, Collatamp®, CollaGUARD®, Collieva®, CollaCare®, Collexa®, Cogenzia® LidoColl®, LiquiColl®, and XaraColl® are registered trademarks, and CollaPress™, DermaSil™, Durieva™, and Zorpreva™ are trademarks of the company.
Pepe CarmonaChief Financial Officer (215) 983-3362 firstname.lastname@example.org Investor Contact: Russo Partners, LLC Robert E. Flamm, Ph.D. (212) 845-4226 email@example.com